ReportWire

Tag: PIII

  • Lake Street Capital Has Lowered Expectations for P3 Health Partners (NASDAQ:PIII) Stock Price

    [ad_1]

    P3 Health Partners (NASDAQ:PIII – Get Free Report) had its target price lowered by equities researchers at Lake Street Capital from $20.00 to $12.50 in a report issued on Monday, Marketbeat.com reports. The brokerage presently has a “buy” rating on the stock. Lake Street Capital’s target price points to a potential upside of 95.31% from the stock’s previous close.

    Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of P3 Health Partners in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $12.50.

    View Our Latest Stock Analysis on PIII

    P3 Health Partners Stock Up 7.0%

    PIII opened at $6.40 on Monday. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.31 and a current ratio of 0.32. The company has a market capitalization of $46.02 million, a PE ratio of -0.16 and a beta of 0.84. The stock’s fifty day moving average is $8.52 and its 200-day moving average is $7.64. P3 Health Partners has a one year low of $5.80 and a one year high of $14.50.

    P3 Health Partners (NASDAQ:PIII – Get Free Report) last released its earnings results on Friday, November 14th. The company reported ($9.67) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($8.70) by ($0.97). P3 Health Partners had a negative return on equity of 302.33% and a negative net margin of 9.07%.The firm had revenue of $345.25 million for the quarter, compared to analyst estimates of $346.64 million. P3 Health Partners has set its FY 2025 guidance at EPS. On average, equities analysts predict that P3 Health Partners will post -0.67 EPS for the current fiscal year.

    Institutional Trading of P3 Health Partners

    An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC grew its holdings in P3 Health Partners Inc. (NASDAQ:PIII – Free Report) by 4.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,678 shares of the company’s stock after purchasing an additional 1,178 shares during the period. Trinity Financial Advisors LLC owned approximately 0.37% of P3 Health Partners worth $239,000 as of its most recent SEC filing. Institutional investors own 7.75% of the company’s stock.

    P3 Health Partners Company Profile

    (Get Free Report)

    P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.

    See Also



    Receive News & Ratings for P3 Health Partners Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for P3 Health Partners and related companies with MarketBeat.com’s FREE daily email newsletter.

    [ad_2]

    ABMN Staff

    Source link

  • Pacific Founders Ugp I. Chicago Buys 90,000 Shares of P3 Health Partners Inc. (NASDAQ:PIII) Stock

    Pacific Founders Ugp I. Chicago Buys 90,000 Shares of P3 Health Partners Inc. (NASDAQ:PIII) Stock

    [ad_1]

    P3 Health Partners Inc. (NASDAQ:PIII – Get Free Report) major shareholder Pacific Founders Ugp I. Chicago bought 90,000 shares of P3 Health Partners stock in a transaction that occurred on Wednesday, August 30th. The shares were acquired at an average cost of $1.83 per share, for a total transaction of $164,700.00. Following the acquisition, the insider now owns 49,305,442 shares in the company, valued at approximately $90,228,958.86. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

    P3 Health Partners Trading Up 0.5 %

    Shares of PIII opened at $1.98 on Friday. The stock has a market capitalization of $619.10 million, a P/E ratio of 0.00 and a beta of 1.23. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 16.13. The firm has a fifty day simple moving average of $2.32 and a two-hundred day simple moving average of $2.16. P3 Health Partners Inc. has a twelve month low of $0.70 and a twelve month high of $7.05.

    P3 Health Partners (NASDAQ:PIII – Get Free Report) last announced its quarterly earnings results on Monday, August 7th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.15. P3 Health Partners had a negative net margin of 10.92% and a negative return on equity of 2,471.27%. The business had revenue of $329.09 million during the quarter, compared to analysts’ expectations of $303.30 million. On average, research analysts anticipate that P3 Health Partners Inc. will post -0.96 EPS for the current year.

    Wall Street Analyst Weigh In

    Several equities analysts recently commented on the stock. BTIG Research initiated coverage on shares of P3 Health Partners in a report on Thursday. They set a “buy” rating on the stock. TD Cowen initiated coverage on shares of P3 Health Partners in a research report on Friday, June 30th. They set a “market perform” rating for the company.

    View Our Latest Stock Report on P3 Health Partners

    Institutional Inflows and Outflows

    Large investors have recently bought and sold shares of the business. Marietta Investment Partners LLC bought a new stake in P3 Health Partners during the 1st quarter valued at about $26,000. Squarepoint Ops LLC bought a new stake in P3 Health Partners during the 4th quarter valued at about $31,000. Walleye Trading LLC bought a new stake in P3 Health Partners during the 2nd quarter valued at about $34,000. State Board of Administration of Florida Retirement System bought a new stake in P3 Health Partners during the 2nd quarter valued at about $34,000. Finally, SlateStone Wealth LLC bought a new stake in P3 Health Partners during the 2nd quarter valued at about $39,000. 23.57% of the stock is owned by hedge funds and other institutional investors.

    P3 Health Partners Company Profile

    (Get Free Report)

    P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

    Featured Stories

    Insider Buying and Selling by Quarter for P3 Health Partners (NASDAQ:PIII)

    Receive News & Ratings for P3 Health Partners Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for P3 Health Partners and related companies with MarketBeat.com’s FREE daily email newsletter.

    [ad_2]

    ABMN Staff

    Source link